These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 27084250)

  • 1. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.
    Masaki Y; Kawabata H; Takai K; Kojima M; Tsukamoto N; Ishigaki Y; Kurose N; Ide M; Murakami J; Nara K; Yamamoto H; Ozawa Y; Takahashi H; Miura K; Miyauchi T; Yoshida S; Momoi A; Awano N; Ikushima S; Ohta Y; Furuta N; Fujimoto S; Kawanami H; Sakai T; Kawanami T; Fujita Y; Fukushima T; Nakamura S; Kinoshita T; Aoki S
    Int J Hematol; 2016 Jun; 103(6):686-92. PubMed ID: 27084250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proposed diagnostic criteria, disease severity classification, and treatment strategy for a novel disorder; TAFRO syndrome].
    Masaki Y; Kawabata H; Takai K; Tsukamoto N; Fujimoto S; Ishigaki Y; Kurose N; Kojima M; Nakamura S; Kinoshita T; Aoki S;
    Rinsho Ketsueki; 2016; 57(10):2029-2037. PubMed ID: 27795511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
    Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
    Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
    Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
    Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
    Fujiwara Y; Ito K; Takamura A; Nagata K
    J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
    Zhou Q; Zhang Y; Zhou G; Zhu J
    BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
    Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
    J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
    Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A
    Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Treatment with Cyclosporin A in Tocilizumab-resistant TAFRO Syndrome.
    Yamaga Y; Tokuyama K; Kato T; Yamada R; Murayama M; Ikeda T; Yamakita N; Kunieda T
    Intern Med; 2016; 55(2):185-90. PubMed ID: 26781021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.
    Iwaki N; Fajgenbaum DC; Nabel CS; Gion Y; Kondo E; Kawano M; Masunari T; Yoshida I; Moro H; Nikkuni K; Takai K; Matsue K; Kurosawa M; Hagihara M; Saito A; Okamoto M; Yokota K; Hiraiwa S; Nakamura N; Nakao S; Yoshino T; Sato Y
    Am J Hematol; 2016 Feb; 91(2):220-6. PubMed ID: 26805758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).
    Kawabata H; Takai K; Kojima M; Nakamura N; Aoki S; Nakamura S; Kinoshita T; Masaki Y
    J Clin Exp Hematop; 2013; 53(1):57-61. PubMed ID: 23801135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT findings in 11 patients with TAFRO syndrome: a variant of multicentric Castleman's disease.
    Kiguchi T; Sato C; Takai K; Nakai Y; Kaneko Y; Matsuki M
    Clin Radiol; 2017 Oct; 72(10):905.e1-905.e5. PubMed ID: 28629605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
    Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y
    Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.
    Sakai K; Maeda T; Kuriyama A; Shimada N; Notohara K; Ueda Y
    Mod Rheumatol; 2018 May; 28(3):564-569. PubMed ID: 26886414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAFRO Syndrome: Guidance for Managing Patients Presenting Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly.
    Miura K; Nishimaki-Watanabe H; Takahashi H; Nakagawa M; Otake S; Hamada T; Koike T; Iizuka K; Takeuchi Y; Kurihara K; Endo T; Ito S; Nukariya H; Namiki T; Hayashi Y; Nakamura H
    Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stepwise Treatment for TAFRO Syndrome.
    Ide M; Yokoyama T; Ishikawa M; Kojima K
    J Med Cases; 2023 Nov; 14(11):369-377. PubMed ID: 38029058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report.
    Noda-Narita S; Sumida K; Sekine A; Hoshino J; Mise K; Suwabe T; Hayami N; Yamanouchi M; Ueno T; Mizuno H; Kawada M; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K; Ohashi K; Fujii T; Ubara Y
    CEN Case Rep; 2018 May; 7(1):162-168. PubMed ID: 29468524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computed tomography findings of early-stage TAFRO syndrome and associated adrenal abnormalities.
    Kurokawa R; Gonoi W; Yokota H; Isshiki S; Ohira K; Mizuno H; Kiguchi T; Inui S; Kurokawa M; Kato S; Matsuki M; Takeda T; Yokoyama K; Ota Y; Nakai Y; Maeda E; Mori H; Abe O
    Eur Radiol; 2020 Oct; 30(10):5588-5598. PubMed ID: 32440781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Thrombocytopenia, Anasarca (Edema, Pleural Effusion, and Ascites), Fever, Reticulin Fibrosis/Renal Dysfunction, and Organomegaly (TAFRO) Syndrome Initially Not Presenting With Thrombocytopenia: A Role of Immature Platelet Fraction.
    Kanda M; Kitamura K; Saito A; Hayashi K; Suzuki T
    Cureus; 2024 Apr; 16(4):e58772. PubMed ID: 38779246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging.
    Nara M; Komatsuda A; Itoh F; Kaga H; Saitoh M; Togashi M; Kameoka Y; Wakui H; Takahashi N
    Intern Med; 2017; 56(10):1247-1252. PubMed ID: 28502946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.